Breast Cancer Vaccine Trials To Start Within Two Years
A biotech company owned by the Cleveland Clinic has developed a vaccine for breast cancer.
Clinic physician Vincent Tuohy says the vaccine follows eleven years of research into a solution for women at risk of the most-lethal forms of breast cancer. He says it stimulates a person's immune system to target cancer cells.
Tuohy says clinical trials are expected to begin within two years.